Evidence map›Paper›PMID 36978433›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Myco-Nanofabrication of Silver Nanoparticles by

Muthuraj Rudrappa, Raju Suresh Kumar, Shashiraj Kareyellappa Nagaraja, Halaswamy Hiremath, Pooja Vidyasagar Gunagambhire, Abdulrahman I Almansour, Karthikeyan Perumal, Sreenivasa Nayaka

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Eco-friendly nanoparticles fromNanoscale advances · 2026
    Article
  7. Article
  8. Article
  9. Phytofabricated Silver Nanoparticles FromFood science & nutrition · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Muthuraj RudrappaP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0003-3406-1648
Raju Suresh KumarDepartment of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-3754-4223
Shashiraj Kareyellappa NagarajaP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0003-4920-6459
Halaswamy HiremathP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.
Pooja Vidyasagar GunagambhireP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.
Abdulrahman I AlmansourDepartment of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Karthikeyan PerumalDepartment of Chemistry and Biochemistry, The Ohio State University, 151 W. Woodruff Ave, Columbus, OH 43210, USA.
Sreenivasa NayakaP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0002-7339-5715
Karnatak University · INKing Saud University · SAThe Ohio State University · US

Funding

Researchers Supporting Project, King Saud University, Riyadh, Saudi Arabia. Project number: RSP2023R142
6 · The paper itself

Abstract

Currently, the exploration of fungal organisms for novel metabolite production and its pharmacological applications is much appreciated in the biomedical field. In the present study, the fungal strains were isolated from soil of unexplored Yellapura regions. The potent isolate NP5 was selected based on preliminary screening and identified as

Indexed as

anticancer activityantimicrobial activityMDA-MB-231 breast cancer cellsPenicillium sp.silver nanoparticlesSPF

Identifiers

PMID36978433
PMCPMC10044662
OpenAlexW4324151711

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read102
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.